biotech · Major Depressive Disorder · Alzheimer's Disease · NMRA
Neumora Therapeutics
Neumora Therapeutics is a biotech organization headquartered in copenhagen, DK. It trades on NYSE under ticker NMRA. Primary therapeutic focus areas include Major Depressive Disorder, Alzheimer's Disease, Major Depressiv
copenhagen, DK HQ
18 Employees
Public company Type
NMRA · NYSE Ticker
Company details
- Status
- Public
- HQ
- copenhagen, DK
- Employees
- 18
- Programs
- 5
- Drugs
- 2
- Patents
- 6
NMRA-335140
Phase 3 · small molecule · Major Depressive Disorder
NMRA-335140 for Major Depressive Disorder is a Phase 3 program (small_molecule) at Neumora Therapeutics with 5 ClinicalTrials.gov record(s).
Internal code NMRA-335140-303
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Neumora Therapeutics
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Major Depressive Disorder
- Status
- active
- Trials
- 5